Determining Kinetics Parameters of Oxidase-Like Ce/Fe-Bimetallic Nanozymes Toward 3,3′,5,5′-Tetramethylbenzidine Oxidation
Archives of Case Reports: Open Access · 2024
DOI: 10.33140/acroa.01.02.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Case Reports: Open Access, 2024. Verfasst von Mohammad Reza Hormozi Jangi und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Herein, kinetics parameters, Km and Vmax, of oxidase-like Ce/Fe-bimetallic nanozymes toward 3,3′,5,5′-tetramethylbenzidine oxidation were determined. The Michaelis–Menten kinetic model was used for the evaluation of the kinetic of the nanozymemediated oxidation of 3,3′,5,5′-tetramethylbenzidine. To provide the quantitative and accurate values of kinetics parameters, Km and Vmax, the linear plot of Lineweaver–Burk was constructed. The results exhibited a Vmax as high as 67.56 nM min-1 for the oxidase-like Ce/Fe-bimetallic nanozymes. Besides, Km was found to be as low as 0.06 mM for the as-prepared nanozymes, revealing the high affinity of the nanozymes toward 3,3′,5,5′-tetramethylbenzidine. Moreover, the ratio Vmax/Km was estimated as a reliable index of catalytic efficiency of the nanozymes, revealing a high value of 1.0×10-3 min-1.
Zitieren
APA
Jangi, M. R. H., & Jangi, A. R. H. (2024). Determining Kinetics Parameters of Oxidase-Like Ce/Fe-Bimetallic Nanozymes Toward 3,3′,5,5′-Tetramethylbenzidine Oxidation. Archives of Case Reports: Open Access. https://doi.org/10.33140/acroa.01.02.02
Vancouver
Jangi MRH, Jangi ARH. Determining Kinetics Parameters of Oxidase-Like Ce/Fe-Bimetallic Nanozymes Toward 3,3′,5,5′-Tetramethylbenzidine Oxidation. Archives of Case Reports: Open Access. 2024. doi:10.33140/acroa.01.02.02
BibTeX
@article{Jangi2024,
author = {Jangi, Mohammad Reza Hormozi and Jangi, Ali Reza Hormozi},
title = {Determining Kinetics Parameters of Oxidase-Like Ce/Fe-Bimetallic Nanozymes Toward 3,3′,5,5′-Tetramethylbenzidine Oxidation},
journal = {Archives of Case Reports: Open Access},
year = {2024},
doi = {10.33140/acroa.01.02.02}
}
EUVIMED